Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CYLD inhibits NFASC. 2 / 2

| 2

➶

reach

"Similarly, CYLD is also known to inhibit NFκB signaling and therefore, inhibitory phosphorylation of CYLD will also serve to enhance expression of prosurvival genes."

32024820

➶

reach

"Using a shRNA library targeting 50 DUBs to identify candidates involved in the regulation of cancer related pathways, they demonstrated that knockdown of CYLD enhanced NF‐κB signalling following Tumour Necrosis Factor (TNF) stimulation (108)."

20073038

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...